The molecular mechanism of peroxisome proliferator action: a model for species differences and mechanistic risk assessment
- 1 December 1992
- journal article
- review article
- Published by Elsevier in Toxicology Letters
- Vol. 64-65, 131-139
- https://doi.org/10.1016/0378-4274(92)90182-j
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Induction of rat liver DNA alterations by chronic administration of peroxisome proliferators as detected by 32P-postlabelingMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1991
- Peroxisome proliferation and nongenotoxic carcinogenesis: Commentary on a symposium*1Fundamental and Applied Toxicology, 1991
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990
- Failure of the peroxisome proliferator WY-14,643 to initiate growth-selectible foci in rat liverToxicology, 1989
- Biochemical Mechanisms of Induction of Hepatic Peroxisome ProliferationAnnual Review of Pharmacology and Toxicology, 1989
- A species comparison of acute hyperplasia induced by the peroxisome proliferator methylclofenapate: involvement of the binucleated hepatocyteCarcinogenesis: Integrative Cancer Research, 1988
- Peroxisome proliterators and cancer: mechanisms and implicationsTrends in Pharmacological Sciences, 1986
- Detection of a nafenopin-binding protein in rat liver cytosol associated with the induction of peroxisome proliferation by hypolipidemic compoundsBiochemical and Biophysical Research Communications, 1983
- Carcinogenesis by Hepatic Peroxisome Proliferators: Evaluation of the Risk of Hypolipidemic Drugs and Industrial Plasticizers to HumansCRC Critical Reviews in Toxicology, 1983
- NATURE OF THE HEPATOMEGALIC EFFECT PRODUCED BY ETHYL-CHLOROPHENOXY-ISOBUTYRATE IN THE RATNature, 1965